# Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

> **NCT07400458** · NA · RECRUITING · sponsor: **Pharmicell Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **BIOLOGICAL:** Hearticellgram-AMI

## Key facts

- **NCT ID:** NCT07400458
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-03
- **Primary completion:** 2028-10-12
- **Final completion:** 2032-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07400458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07400458, "Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07400458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*